Feb. 2 (Gephardt Daily/UPI) — President Joe Biden on Wednesday will announce that he’s reviving an effort to fight cancer, which he began when he was vice president, and unveil a plan to reduce cancer deaths in the United States by 50% within 25 years, the White House said. The announcement comes six years after Biden,…
The Biden administration on Wednesday announced the relaunch of the Cancer Moonshot initiative, which was first launched in 2016, with the goal of cutting the cancer death rate in half over the next 25 years. Details on the initiative According to a White House statement, the initiative’s goals will include reducing the age-adjusted cancer death rate by…
THURSDAY, Feb. 3, 2022 (HealthDay News) — President Joe Biden announced Wednesday that he is giving a new push to the cancer moonshot initiative that he first led during the Obama administration. In his announcement, Biden said the program would aim to boost prevention, screening and research with a target of reducing the cancer death rate…
To scientists’ relief, the “reignited” Cancer Moonshot to be formally announced today by President Joe Biden will not offer an unrealistic deadline for wiping out cancer. It instead sets a long-term goal of gradually reducing cancer deaths. The plan would focus research in several areas, including preventive vaccines and blood tests that screen for multiple…
President Joe Biden’s reignited moonshot to halve cancer deaths, improve care and eventually end the disease gives a lift to one of his longest-held and most personal goals — but the mission hasn’t been refueled. Missing from the ambitious plan to boost screening, reduce inequities and strengthen prevention efforts is a funding boost to the existing…
Lawmakers are considering how to package and pass overlapping proposals on biomedical innovation and pandemic preparedness before a top senator’s retirement at the end of the year. The good news is all the proposals have bipartisan support. The bad news is Congress is already overloaded with other agenda items, such as Democrats’ social spending measure,…
Dr. Edward S. Kim is a widely respected cancer researcher known for his work on the molecular prognostication of lung cancer. But where his extraordinary brilliance lies is in his executive leadership — as he works to change the way cancer care is accessed. He is bringing unprecedented levels of advanced care to the community…
In 2021, the FDA’s crack down on accelerated approvals meant the removal of several immunotherapy indications from the US market. In an editorial from FDA faculty members, Julia A. Beaver, MD; and Richard Pazdur, MD, they explained that in the 29 years that the accelerated approval pathway has existed, over 155 accelerated approvals for oncology…
Fifty years ago, President Nixon signed the National Cancer Act into law to restructure the country’s way of dealing with a leading cause of death and suffering. Cancer cases were increasing, and a new approach to fight it was needed. The Act set forth a National Cancer Program to strengthen the role of the federal…
Clinical trials provide evidence to support what you do in your work as a nurse every day. They are tools to discover new therapies and identify side effects while considering patient-specific factors like age, comorbidities, race, and sex. They build support for best practices in treatment and patient care. As with many aspects of oncology,…
